Used primarily in pharmaceutical research, this compound serves as a key intermediate in the synthesis of various biologically active molecules. Its structure is particularly valuable in the development of potential therapeutic agents targeting neurological disorders, such as depression and anxiety, due to its ability to interact with specific neurotransmitter systems. Additionally, it is explored in the creation of novel compounds for cardiovascular and metabolic disease research, where its fluorinated chroman core enhances binding affinity and selectivity. Researchers also investigate its role in designing new drugs with improved pharmacokinetic properties.